Drug intelligence / Profile preview

Nyxoid

Development stage
Unknown
Lead developer
Mundipharma
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Intranasal
01

Overview

Nyxoid is a single-dose intranasal spray formulation of naloxone hydrochloride dihydrate, indicated for the emergency treatment of known or suspected opioid overdose in adults and adolescents aged 14 years and over. Naloxone is an opioid receptor antagonist that rapidly displaces opioids from their receptors in the central nervous system, temporarily reversing life-threatening respiratory and central nervous system depression caused by opioids such as heroin, methadone, fentanyl, oxycodone, buprenorphine, or morphine. The onset of action occurs within two to five minutes after administration and lasts approximately 30–90 minutes. Nyxoid is intended as an emergency rescue medication while awaiting medical attention; it does not replace the need for immediate professional care[1][2][4][5][7][10].

Brand names
Nyxoid
Other names
naloxone nasal spraynaloxone hydrochloride dihydrate nasal spray
02

Targets

KOR (Kappa opioid receptor)MOR (Mu opioid receptor)DOR (Opioid Receptor Delta 1)

Beyond the preview

Go deeper on Nyxoid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nyxoid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call